(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

DERIVADOS DE IMIDAZOLINONA N-SUBSTITUÍDOS, SUA PREPARAÇÃO E COMPOSIÇÕES FARMACÊUTICAS CONTENDO OS MESMOS

Em AnálisePatente Pipeline

Application data

Number

PP1100054

Type

Patente Pipeline

Filing

09/27/1996

Publication

02/04/1997

Progress at the INPI

  1. Filing09/27/96
  2. Publication02/04/97
  3. Examination
  4. Allowance
  5. Grant
  6. In force

Published on 02/04/1997, the application is awaiting technical examination at the INPI, which decides whether the invention meets the patentability requirements.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 11/09/2010. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

Sanofi

FR

Sanofi-Aventis

FR

Sanofi-Synthelabo

FR

See this company's full portfolio

Inventors

C. B. (pessoa física)

FR

J. B. (pessoa física)

FR

Technical data

Priority claims

FR

90 03563 · 03/20/1990

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

15.12

Renumerado o pedido de PI1100054-6 para PP1100054-6.

11/09/2010

RPI 2079

Alteração de nome deferida

#25.4

Alterado de: Sanofi-Synthelabo

04/10/2007

RPI 1892

22.15

INPI-52400.0033679/05 @ Origem: Juízo da 38ª VF do Rio de Janeiro. @ Processo Nº 2005.51.01.519570-0. @ Ação de Procedimento Ordinário @ Autor: Sanofi-Synthelabo.

11/29/2005

RPI 1821

Transferência deferida

#25.1

Transferido de: Sanofi

10/28/2003

RPI 1712

Alteração de sede deferida

#25.7

Alterada a sede do depositante conforme solicitado na petição nº 045947/RJ de 20/08/2002.

09/30/2003

RPI 1708

23.9

05/04/1999

RPI 1478

23.2

09/29/1998

RPI 1449

23.13

09/22/1998

RPI 1448

23.11

08/19/1997

RPI 1394

23.11

07/29/1997

RPI 1391

23.3

02/04/1997

RPI 1366

Pedido dividido

#23.1

11/05/1996

RPI 1353

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.